Linda Feldbrügge Selected Research

Linda Feldbrügge Research Topics

Disease

8	Fibrosis (Cirrhosis) 07/2023 - 01/2016
8	Inflammation (Inflammations) 09/2022 - 01/2011
6	Liver Cirrhosis (Hepatic Cirrhosis) 09/2022 - 01/2016
5	Neoplasm Metastasis (Metastasis) 12/2022 - 01/2019
3	Stomach Neoplasms (Stomach Cancer) 04/2022 - 01/2020
2	Hepatocellular Carcinoma (Hepatoma) 06/2021 - 01/2019
2	Crohn Disease (Crohn's Disease) 11/2018 - 09/2017
2	Colitis 11/2018 - 09/2017
2	Non-alcoholic Fatty Liver Disease 01/2018 - 01/2016
2	Sepsis (Septicemia) 10/2017 - 10/2017
2	Ischemia 01/2011 - 01/2010
1	Surgical Wound Infection 12/2022
1	Infections 12/2022
1	Cross Infection (Nosocomial Infection) 12/2022
1	Anastomotic Leak 08/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Acute Kidney Injury (Acute Renal Failure) 01/2022
1	Peritoneal Neoplasms 01/2022
1	Postoperative Hemorrhage 09/2021
1	Postoperative Pain 09/2021
1	Leukocytosis (Pleocytosis) 05/2020
1	Hepatitis 05/2020
1	Neoplasms (Cancer) 01/2019
1	Hypoxia (Hypoxemia) 11/2018
1	Cholangiocarcinoma 07/2018
1	Brain Injuries (Brain Injury) 10/2017
1	Delirium 10/2017
1	Fatty Liver 01/2016
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2016
1	Post-Cardiac Arrest Syndrome 01/2011
1	Heart Diseases (Heart Disease) 01/2011
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2010

Drug/Important Bio-Agent (IBA)

3	ectoATPaseIBA 08/2020 - 09/2017
3	NucleosidesIBA 12/2018 - 09/2017
2	CollagenIBA 01/2019 - 01/2018
2	3,5- diethoxycarbonyl- 1,4- dihydrocollidineIBA 01/2019 - 01/2018
2	Adenosine (Adenocard)FDA LinkGeneric 01/2019 - 10/2017
2	triphosphoric acid (triphosphate)IBA 01/2018 - 09/2017
2	EnzymesIBA 01/2018 - 09/2017
2	NucleotidesIBA 01/2018 - 10/2017
2	Adenosine Triphosphate (ATP)IBA 10/2017 - 12/2014
2	CytokinesIBA 10/2017 - 10/2017
2	Purinergic P2X7 ReceptorsIBA 10/2017 - 10/2017
2	nasIBA 03/2016 - 01/2016
1	Vancomycin FDA LinkGeneric 12/2022
1	Heme Oxygenase-1IBA 09/2022
1	Urea (Carbamide)FDA LinkGeneric 01/2022
1	sodium thiosulfate FDA Link 01/2022
1	Cisplatin (Platino)FDA LinkGeneric 01/2022
1	Cell-Free Nucleic AcidsIBA 05/2020
1	C-Reactive ProteinIBA 05/2020
1	RamucirumabIBA 01/2020
1	AerosolsIBA 01/2020
1	NF-kappa B (NF-kB)IBA 01/2019
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2019
1	Purinergic P1 Receptor AntagonistsIBA 01/2019
1	Coffee FDA Link 01/2019
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 11/2018
1	BilirubinIBA 11/2018
1	LigandsIBA 11/2018
1	XenobioticsIBA 11/2018
1	Dextran SulfateIBA 11/2018
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 11/2018
1	Ritonavir (Norvir)FDA Link 11/2018
1	Therapeutic UsesIBA 11/2018
1	MicroRNAs (MicroRNA)IBA 07/2018
1	Biomarkers (Surrogate Marker)IBA 07/2018
1	AngiopoietinsIBA 07/2018
1	Adenosine DeaminaseIBA 01/2018
1	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2018
1	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 10/2017
1	Dextrans (Dextran)FDA Link 09/2017
1	SodiumIBA 09/2017
1	Apyrase (ATP Diphosphatase)IBA 09/2017
1	Proteins (Proteins, Gene)FDA Link 01/2016
1	VLDL LipoproteinsIBA 01/2016
1	Keratin-18 (Keratin 18)IBA 01/2016
1	Lipoproteins (Lipoprotein)IBA 01/2016
1	Phenobarbital (Luminal)FDA Link 01/2016
1	Messenger RNA (mRNA)IBA 01/2016
1	Adenosine Diphosphate (ADP)IBA 12/2014
1	Annexin A5IBA 01/2011

Therapy/Procedure

4	Hyperthermic Intraperitoneal Chemotherapy 12/2022 - 06/2021
4	Cytoreduction Surgical Procedures 12/2022 - 06/2021
3	Ligation 09/2022 - 10/2017
3	Drug Therapy (Chemotherapy) 08/2022 - 01/2020
3	Liver Transplantation 06/2021 - 01/2019
2	Therapeutics 08/2022 - 01/2020
2	Combined Modality Therapy 08/2022 - 01/2022
2	Aftercare (After-Treatment) 08/2022 - 01/2019
2	Hepatectomy 12/2020 - 01/2018
2	Cardiopulmonary Resuscitation (CPR) 01/2011 - 01/2010
2	Resuscitation 01/2011 - 01/2010
1	Operative Time 07/2023
1	Stents 08/2022
1	Neoadjuvant Therapy 08/2022
1	Chemoradiotherapy 08/2022
1	Length of Stay 09/2021
1	Transplantation 06/2021
1	Punctures 10/2017